New Delhi: The National Pharmaceutical Pricing Authority (NPPA), India’s drug-price regulator, has approved a price increase of over 50 per cent for essential drugs used to treat medical conditions like asthma, glaucoma, thalassemia, tuberculosis, and mental health issues. According to the Ministry of Health and Family Welfare, the decision was made on October 8, during a full Authority meeting, utilising the extraordinary powers granted under Para 19 of the Drugs (Prices Control) Order, 2013.
Why Were The Prices Revised?The NPPA revised the ceiling prices of eight scheduled drugs to meet the “twin objectives of availability and affordability”, the authority claimed in a press release. “Most of these drugs are low-cost and generally used as first-line treatment crucial to the public health programmes of the country.”Eleven formulations for which ceiling prices have been revised include benzylpenicillin (10 lakh IU injection), atropine injection (0.6 mg per ml), streptomycin powder (for injection 750 mg and 1000 mg), salbutamol tablet (2 mg and 4 mg), respirator solution (5 mg per ml), Pilocarpine 2% drops, Cefadroxil tablet (500 mg), Desferrioxamine (500 mg for injection) and Lithium tablets (300 mg).These medications are often used as first-line treatments in public health programs, and the price adjustments aim to prevent shortages or market withdrawal due to production challenges. How Much The Medicines Will Cost Now?The cost of these medicines will range Rs 1.02 per ml solution to Rs 16.25 per ml drop, with the exception of a more expensive Desferroxamine that will cost a little over Rs 280 per vial.Notably, the medicines for which the prices have been increased are not very expensive to begin with. So the 50 per cent increase in ceiling prices is unlikely to hit people very hard. Similar measures were taken in 2019 and 2021, when ceiling prices for 21 and 9 formulations, respectively, were increased by 50 per cent. These interventions highlight the NPPA's ongoing efforts to strike a balance between maintaining drug affordability and ensuring their availability, particularly for treatments that are crucial to the nation's healthcare system.You may also like
Will bring law to prevent mixing of human waste with food: CM Yogi Adityanath
Rising car insurance premiums cannot be justified - we must put motorists back in the driving seat
Teens extort Rs 7L from 12-year-old girl
Israel to launch 'revenge attack' on Iran military targets in first of 'series of reactions'
Who Is Giovanny Aldama Garcia? Florida Man Charged With Animal Cruelty For Abandoning Dog During Hurricane Milton
British war photographer found murdered in mountainous area
Who Was Guilherme 'Bomba' Vasconcelos? MMA Fighter Dies At 38
Princess Kate's powerful message of 'love, strength and hope' over baby loss tragedy
Maharashtra Assembly Elections 2024: Government Issues 244 Resolutions Hours Before Poll Announcement
Sri Lankan Airlines Captain Locks Co-Pilot Out Of Cockpit After Mid-Air Argument, Gets Grounded
Cong panel to submit tech report on EVM
Rats and 'fire-starting squirrels' set to invade Britain's homes to avoid winter freeze
Man Utd move to terminate Sir Alex Ferguson contract slammed by Dwight Yorke
13 players who featured for Liverpool and Chelsea including Fernando Torres and forgotten stars
Coronation Street fans 'work out' pregnancy bombshell after Joel Deering confirmed dead
Quota row puts an out-of-sync Mahayuti in a tighter spot
Mumbai: BMC Appoints Project Management Consultant For Coastal Road Phase 2, Investing ₹559 Crore In Services
Prince William's surprising talent he learned when he was younger
Man shows off world's smallest home that measures just 19 square feet and costs him tiny sum
Traitors' Harry Clark axed from Celebrity SAS after he was caught lying during interrogation